| P50 | author | Jonathan Carapetis | Q6272711 |
| | Andrew C Steer | Q90356508 |
| | Nigel Curtis | Q30513816 |
| P2860 | cites work | Exotoxins of Staphylococcus aureus | Q24550718 |
| | Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | Q24561897 |
| | Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin | Q24601968 |
| | Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment | Q24648318 |
| | The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician | Q28254306 |
| | Pathogenesis of group A streptococcal infections | Q29615547 |
| | Severe streptococcal infections in historical perspective | Q30350200 |
| | The flesh-eating bacterium: what's next? | Q33542363 |
| | NSAIDS and necrotizing fasciitis | Q33720334 |
| | Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). | Q33753352 |
| | Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection | Q33802451 |
| | The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections | Q33979669 |
| | The global burden of group A streptococcal diseases | Q33991045 |
| | Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus | Q34007228 |
| | Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. | Q34049486 |
| | Immunogenicity of a 26-valent group A streptococcal vaccine. | Q34121015 |
| | Superantigens: microbial agents that corrupt immunity | Q34123105 |
| | The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis | Q34172694 |
| | Interplay between superantigens and immunoreceptors | Q34309339 |
| | The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction | Q34310647 |
| | Group A streptococcal meningitis: report of a case and review of literature since 1976. | Q34468549 |
| | Intravenous immunoglobulin for prophylaxis and therapy of sepsis | Q34503036 |
| | A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome | Q34580488 |
| | Clinical characteristics of necrotizing fasciitis caused by group G Streptococcus: case report and review of the literature | Q34771544 |
| | Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin | Q34782834 |
| | Fulminant group A streptococcal necrotizing fasciitis: clinical and pathologic findings in 7 patients | Q34883721 |
| | Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome | Q35551435 |
| | Neonatal invasive group A streptococcal disease: case report and review of the literature | Q35661392 |
| | Progress in group A streptococcal vaccine development | Q35856273 |
| | Invasive group A streptococcus infections | Q36043514 |
| | The diagnosis of necrotizing fasciitis | Q36056554 |
| | Invasive group a streptococcal infections, Israel | Q37314025 |
| | As a bacterial culture medium, citrated sheep blood agar is a practical alternative to citrated human blood agar in laboratories of developing countries. | Q38475241 |
| | Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection | Q38897182 |
| | Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat | Q38906624 |
| | Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment | Q39471628 |
| | Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. | Q40449990 |
| | Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella | Q40602600 |
| | Invasive group A streptococcal infections in children with varicella in Southern California. | Q40672431 |
| | Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? | Q40679161 |
| | Bacteriology of necrotizing fasciitis | Q40786128 |
| | Resurgence of acute rheumatic fever in the intermountain area of the United States | Q40799452 |
| | Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone | Q40962659 |
| | Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. | Q41218136 |
| | The toxic shock syndromes | Q41260248 |
| | Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review | Q41508695 |
| | Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study | Q41543482 |
| | Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection | Q41727019 |
| | Superantigens and streptococcal toxic shock syndrome | Q42106655 |
| | Clindamycin treatment of chronic pharyngeal carriage of group A streptococci | Q42144595 |
| | Non-steroidal anti-inflammatory drugs may predispose to invasive group A streptococcal infections | Q42378229 |
| | T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor | Q42768501 |
| | Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial | Q43470558 |
| | Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci | Q43787288 |
| | Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group | Q44022331 |
| | Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings | Q44471835 |
| | Streptococcal pneumonia and empyema in childhood | Q44565654 |
| | Invasive group A streptococcal infections in Florida | Q44626208 |
| | Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group | Q45742616 |
| | Necrotizing fasciitis: a dramatic surgical emergency | Q49191945 |
| | Bacteremia among children admitted to a rural hospital in Kenya | Q50094121 |
| | A 13-year survey of bacteraemia due to -haemolytic streptococci in a Danish county | Q50556501 |
| | The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. | Q50607705 |
| | Varicella-associated invasive group A streptococcal disease in Alberta, Canada--2000-2002. | Q50759633 |
| | Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. | Q50770291 |
| | Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. | Q51710821 |
| | Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study | Q56827565 |
| | Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial | Q56925522 |
| | Prevention of Invasive Group A Streptococcal Disease among Household Contacts of Case Patients and among Postpartum and Postsurgical Patients: Recommendations from the Centers for Disease Control and Prevention | Q57661150 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 289-301 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Expert Opinion on Medical Diagnostics | Q5421210 |
| P1476 | title | Diagnosis and treatment of invasive group A streptococcal infections | |
| P478 | volume | 2 | |